GMP (good manufacturing practice) regulations delayed in Taiwan following opposition
This article was originally published in Clinica
The planned introduction of good manufacturing practice (GMP) requirements for medical device manufacturers in Taiwan has been delayed. GMP regulations were originally due to have been implemented on July 1 with the final deadline for compliance set for July 2004.
You may also be interested in...
Despite so many COVID-19 uncertainties, e.l.f. Beauty has the confidence of a company that posted 6% net sales growth to $283m for the 2020 fiscal year ended on 31 March and is seeing its value proposition for "prestige-quality" cosmetics resonate even more powerfully with consumers in today’s volatile economic climate.
Latest warning to Humaworm notes findings that FDA inspectors made in July 2019. FDA officials apparently have been in Humaworm’s facility since then, executing a search warrant in October and confiscating encapsulating machines, herbs, capsules, computers, and records.
After a tepid performance in the fiscal fourth quarter, Torrent expects its key markets India, US and Brazil to be impacted by the COVID-19 fallout as well as a lack of visibility on regulatory approvals for its manufacturing facilities.